SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
DUBAI, UAE, Jan. 15, 2026 /PRNewswire/ -- Mantle, the high-performance distribution and liquidity layer bridging traditional finance (TradFi), real-world assets (RWAs) and on-chain liquidity, today...